Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my primary obligation is to the patients. While a 40% stock drop is a financial catastrophe, a cover-up that leads to preventable deaths is a corporate death sentence and a moral failure. If we "wait for more data" and another patient dies during that window, we move from "negligence" to "criminal intent."Read the full answer
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer